scholarly journals MUSICOTERAPIA EM PACIENTES COM DOENÇA DE ALZHEIMER – UMA REVISÃO SISTEMÁTICA

2021 ◽  
Author(s):  
Maria Fonseca Soares Ferreira ◽  
Davi Neri Araújo ◽  
Alana Alves Farias ◽  
Vinicius Kolansky Rocha Bittencourt ◽  
Maísa Almeida Silva ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Music Therapy ◽  
Systematic Reviews

A doença de Alzheimer (DA) é a enfermidade neurodegenerativa e progressiva cujo principal sintoma é o déficit na memória. Atualmente, não existe tratamento medicamentoso capaz de aliviar tais pacientes e prolongar a sua independência funcional. Neste cenário, intervenções não farmacológicas mostram-se alternativas apropriadas para a conservação do bem-estar e amusicoterapia é uma alternativa promissora. O presente trabalho objetiva através de uma revisão sistemática, analisar os efeitos obtidos pela intervenção da musicoterapia em pacientes com DA, principalmente no que se refere aos sintomas comportamentais e perda cognitiva. Para isso, realizamos uma pesquisa bibliográfica eletrônica no MEDLINE/PubMed, até o mês de fevereiro de 2020 utilizando os termos: 'Alzheimer's disease' AND 'music therapy' AND 'humans'. Os critérios de inclusão foram: estudos observacionais (coorte, caso controle) e ensaios clínicos randomizados; idiomas: português, inglês eespanhol. Foram excluídos aqueles que utilizaram outras estratégias não farmacológicas em pacientes com DA além da musicoterapia; aqueles artigos cujos participantes apresentavam demência que não DA e para a avaliação da qualidade metodológica dos artigos utilizamos o instrumento Assessment of Multiple Systematic Reviews. Ao todo a pesquisa bibliográfica nos forneceu 160 artigos dentre os quais oito se adequaram integralmente aos critérios de inclusão e qualidade. Os estudos evidenciaram efeitos benéficos do emprego da musicoterapia como intervenção não farmacológica em pacientes com DA, contribuindo na diminuição dos sintomas psicológicos e comportamentais dos pacientes. 

scholarly journals An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer’s Disease

2021 ◽  
Vol 12 ◽  
Author(s):  
Nanyang Liu ◽  
Tingting Zhang ◽  
Jiahui Sun ◽  
Jiuxiu Yao ◽  
Lina Ma ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Herbal Medicine ◽  
Systematic Reviews ◽  
Chinese Herbal Medicine ◽  
Methodological Quality ◽  
Efficacy And Safety ◽  
Quality Of Evidence ◽  
Chinese Herbal

Background: Multiple systematic reviews (SRs) have been conducted to evaluate the efficacy and safety of Chinese herbal medicine (CHM) in patients with Alzheimer’s disease (AD). Here, we aim to perform an overview to assess the methodological quality and quality of evidence of the SRs to provide convincing data on the treatment of AD with CHM.Method: Six electronic databases including Chinese and English were searched, until April 31, 2021. Two researchers independently screen documents and extract data according to the predesigned rules. A Measure Tool to Assessment System Reviews 2 (AMSTAR-2) was used to investigate the methodological quality, and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) was used to determine the quality of evidence for outcomes.Results: Twelve qualified SRs including 163 randomized controlled trials were reviewed. The methodological quality of the included SRs was considered extremely low assessed through AMSTAR-2. Compared with western medicines (WM) alone, CHM as an adjuvant treatment has shown significant effects in improving Mini-mental State Examination, Alzheimer’s Disease Assessment Scale-Cognitive, and Clinical Dementia Rating scores. The same is true for CHM alone. Regarding the effect on Activities Daily Living, neither the single CHM nor the combination with WM has an obvious effect. For the total effective rate, both single CHM and the combination with WM shown significant effects. Nine SRs suggested that CHM as adjuvant therapy or single-use had fewer adverse events than WM. Additionally, the quality of evidence for the main outcome was reviewed as low or extremely low according to GRADE profiler data.Conclusion: Current evidence suggests that CHM may be beneficial in improving the cognitive function of AD patients. However, we should be cautious about the evidence due to methodological flaws and low quality. High-quality RCTs are further needed to confirm the efficacy and safety of CHM for AD.

Effects of Exercise in the Treatment of Alzheimer’s Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses

2021 ◽  
pp. 1-17
Author(s):  
Alexandro Andrade ◽  
Thais Cristina Siqueira ◽  
Anderson D’Oliveira ◽  
Fábio Hech Dominski
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Systematic Reviews ◽  
Web Of Science ◽  
Cochrane Library ◽  
Umbrella Review ◽  
Disease Symptoms ◽  
Moderate Quality ◽  
Low Incidence ◽  
Meta Analyses

The authors aimed to provide an overview of the evidence on the effects of exercise in people with Alzheimer’s disease through a comprehensive review of the existing systematic reviews and meta-analyses. A literature search was performed in CINAHL, Cochrane Library, EMBASE, PubMed, SPORTDiscus, Scopus, and Web of Science databases according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The AMSTAR-2-Tool was used for the quality assessment. Twenty-three reviews fulfilled the criteria. Most of the reviews investigated the effects of aerobic exercise on Alzheimer’s disease symptoms. The largest effects of exercise were seen in terms of improved cognition by multiple exercises. The majority of the reviews were rated as being of moderate quality and none were classified as having high quality. Exercise is an effective way to treat Alzheimer’s disease symptoms and has a low incidence of related adverse events. As most reviews were evaluated as low-moderate quality, caution is needed in the interpretation of the results.

Technological prospecting of music therapy in Alzheimer's disease

2021 ◽  
Vol 10 (16) ◽  
pp. e443101622316
Author(s):  
Murilo Bastos ◽  
Kelby Cavalheiro de Mendonça ◽  
Valquiria Camargo Lins ◽  
Eduardo Muzzolon ◽  
Deise Mara Soares ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Music Therapy ◽  
Memory Loss ◽  
Active Therapy ◽  
Pharmacological Interventions ◽  
Limited Efficacy ◽  
Drug Treatments ◽  
The Subject

Alzheimer's disease (AD) is characterized by cognitive impairment and progressive memory loss and drug treatments have limited efficacy. Thus, non-pharmacological interventions, such as music therapy, have shown to be promising as supporting pharmacological treatment and, therefore, may arouse commercial interest regarding the development of this type of product. Thus, this study aims to carry out a patentometric survey on patent registrations with music therapy in the treatment of AD. A systematic search was carried out from 2000 to 2020 on the Orbti-Questel website, searching for documents referring to music therapies in AD. The terms “Alzheimer music methodology active therapy” and “Alzheimer music methodology passive therapy” were used. After searching, reading, and excluding duplicate results, we found four patent families referring to music therapy in AD and all were selected as a result, which was considered little compared to the number of studies published on the subject.

An overview of the use of music therapy in the context of Alzheimer's disease: A report of a French expert group

Dementia ◽  
2012 ◽  
Vol 12 (5) ◽  
pp. 619-634 ◽  
Author(s):  
Stéphane Guetin ◽  
Kevin Charras ◽  
Alain Berard ◽  
Christophe Arbus ◽  
Patrick Berthelon ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Music Therapy ◽  
Expert Group
Sign in / Sign up

Export Citation Format

Share Document